Abstract:
The invention provides methods of using beta glucans to treat conditions associated with bone loss or low bone density as well as methods for promoting bone growth in situations where enhanced bone growth is desirable. In the invention methods beta glucans are administered so as to enhance the development of osteoblasts and the inhibition of the development and recruitment of osteoclasts. The inhibition of the recruitment and development of osteoclasts, coupled with the enhancement of osteoblast maturation by beta glucans leads to decreased bone resorption and increased bone formation, making beta glucans ideal agents for the treatment of osteoporosis and other bone resorption diseases.
Abstract:
Hollow synthetic fibers useful in reverse osmosis, ultrafiltration, gas separation and the like, having high hydraulic permeability to the solvent and capable of operation at pressures from 600 psi and up, are prepared by forming a solution of a fiber-forming polymer in a suitable solvent, adding to the solution a second polymer soluble in the solvent but with limited compatibility with the first polymer when their total concentration increases on coagulation, extruding the resulting solution through an orifice equipped for coaxial extrusion so that coagulating fluid within tube flow results, precipitating with a liquid which is miscible with the solvent for the fiber-forming material, is a non-solvent for the first polymer and a solvent for the second, contacting the extruded solution with the precipitating liquid either coaxially through the extrusion device or by passing the extrudate through the precipitating liquid, and finally washing the resulting hollow fiber free of residual solvents and non-solvents, and air drying. The coagulating fluid and the precipitating liquid may be the same material. The coagulating fluid may be air or another gas.
Abstract:
The present invention relates generally to the electrophoretic separation of biomolecules, including but not limited to proteins, peptides, DNA and RNA. The methods of this invention are particularly useful when applied to two-dimensional gel electrophoresis.
Abstract:
A water wettable permselective membrane for use in hemodialysis, ultrafiltration and microfiltration applications and a device containing the same are provided. The membrane having the above properties comprises a hydrophobic-base polymer, such as a polysulfone or polyethersulfone polymer, and a block copolymer additive wherein one of the blocks of the copolymer additive is a hydrophilic polymer and the other block is a hydrophobic polymer that is analogous in structure to the hydrophobic-base polymer.
Abstract:
This invention relates to a peritoneal dialysis solution which comprises as an osmotically active agent an osmotically effective amount of a mixture of peptides, the mixture consisting substantially of peptides having a molecular weight of about 300 to about 2000 daltons, and an equivalent weight between about 150 to about 1500.
Abstract:
Affinity membranes are prepared by activation of polyamide microporous films. In particular, the films are activated with 1,1'-carbonyldiimidazole, 2-fluoro-1-methylpyridinium.sup.(+) toluene-4-sulfonate.sup.(-), trichlorotriazine, or derivatives thereof, followed by binding of ligand to the activated sites. The polyamide microporous activated films include composite films comprising polyamide covalently bound to a polyhydroxyl compound such as a polysaccharide.
Abstract:
Hydrophilic semipermeable membranes based on copolymers of acrylonitrile and hydroxy-C.sub.2 -C.sub.4 -alkyl esters of (meth)acrylic acid are provided. The membranes have a substantial water regain at equilibrium, a wide range of ultrafiltration rates, and low solute adsorption by ion-exchange or hydrophobic interaction mechanisms. The membranes are particularly suitable for processing protein containing fluids, especially biological fluids such as blood or plasmas.